Antimicrobial resistance (AMR) – the ability of microorganisms to resist antimicrobials – is the leading infectious health issue across EU/EEA countries and one of the major causes of concern in public health. This paper discusses how public health actions to tackle AMR can have a positive impact on population health and are an excellent investment for EU/EEA countries.
Antimicrobial Resistance Tackling the Burden in the European Union
Tackling the Burden in the European Union
Policy brief
Share
Facebook
Twitter
LinkedIn
Abstract
Related publications
-
20 September 202491 Pages
-
19 March 2024236 Pages
-
Policy brief
Embracing a One Health Approach
20 November 202316 Pages -
14 September 2023382 Pages
-
14 September 202312 Pages
-
7 March 202215 Pages
-
1 April 2020274 Pages